NZ262794A - Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative - Google Patents
Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivativeInfo
- Publication number
- NZ262794A NZ262794A NZ262794A NZ26279494A NZ262794A NZ 262794 A NZ262794 A NZ 262794A NZ 262794 A NZ262794 A NZ 262794A NZ 26279494 A NZ26279494 A NZ 26279494A NZ 262794 A NZ262794 A NZ 262794A
- Authority
- NZ
- New Zealand
- Prior art keywords
- formula
- enterovirai
- compound
- enteroviruses
- enterovirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2352793A | 1993-02-26 | 1993-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ262794A true NZ262794A (en) | 1997-03-24 |
Family
ID=21815649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ262794A NZ262794A (en) | 1993-02-26 | 1994-02-23 | Treating enteroviral infections with a 4-(4-(phenoxymethyl)phenylmethoxy)benzene derivative |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0686032A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH08507062A (cg-RX-API-DMAC7.html) |
| AU (1) | AU691490B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2156916A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI953980A0 (cg-RX-API-DMAC7.html) |
| HU (1) | HUT72490A (cg-RX-API-DMAC7.html) |
| IL (1) | IL108749A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA94001379A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ262794A (cg-RX-API-DMAC7.html) |
| TW (1) | TW284686B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1994018960A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA941244B (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020070390A1 (en) | 2018-10-03 | 2020-04-09 | Jyväskylän Yliopisto | Vemurafenib and salts thereof for use in the treatment of enteroviral infections |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8412799U1 (de) * | 1984-04-26 | 1984-10-31 | William Prym-Werke Kg, 5190 Stolberg | SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln |
| YU63392A (sh) * | 1991-06-19 | 1994-11-15 | Schering Corporation | Bis(oksi) jedinjenja i postupak za njihovo dobijanje |
-
1994
- 1994-02-23 FI FI953980A patent/FI953980A0/fi unknown
- 1994-02-23 CA CA002156916A patent/CA2156916A1/en not_active Abandoned
- 1994-02-23 JP JP6519068A patent/JPH08507062A/ja active Pending
- 1994-02-23 WO PCT/US1994/001605 patent/WO1994018960A1/en not_active Ceased
- 1994-02-23 MX MXPA94001379A patent/MXPA94001379A/es not_active Application Discontinuation
- 1994-02-23 EP EP94910114A patent/EP0686032A1/en not_active Ceased
- 1994-02-23 AU AU62679/94A patent/AU691490B2/en not_active Ceased
- 1994-02-23 NZ NZ262794A patent/NZ262794A/en unknown
- 1994-02-23 HU HU9502494A patent/HUT72490A/hu unknown
- 1994-02-23 IL IL10874994A patent/IL108749A0/xx unknown
- 1994-02-23 ZA ZA941244A patent/ZA941244B/xx unknown
- 1994-02-24 TW TW083101586A patent/TW284686B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| TW284686B (cg-RX-API-DMAC7.html) | 1996-09-01 |
| FI953980L (fi) | 1995-08-24 |
| JPH08507062A (ja) | 1996-07-30 |
| WO1994018960A1 (en) | 1994-09-01 |
| CA2156916A1 (en) | 1994-09-01 |
| HU9502494D0 (en) | 1995-10-30 |
| FI953980A7 (fi) | 1995-08-24 |
| FI953980A0 (fi) | 1995-08-24 |
| ZA941244B (en) | 1994-08-23 |
| EP0686032A1 (en) | 1995-12-13 |
| AU6267994A (en) | 1994-09-14 |
| IL108749A0 (en) | 1994-05-30 |
| MXPA94001379A (es) | 2011-09-26 |
| HUT72490A (en) | 1996-05-28 |
| AU691490B2 (en) | 1998-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tufan et al. | COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs | |
| CA3166282C (en) | USE OF A PHARMACEUTICAL COMPOSITION TO PREVENT AND TREAT THE NOVEL CORONAVIRUS PNEUMONIA | |
| Woods et al. | In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug | |
| KR20120044930A (ko) | 고병원성 감염성 질환의 예방 및 치료제 | |
| TW201306839A (zh) | 治療ｈｃｖ感染之組合療法 | |
| WO2003050129A1 (en) | Use of phosphonate nucleotide analogue for treating hepatitis b virus infections | |
| CN112409379A (zh) | 氘代的二氢二苯并硫杂卓化合物以及包含该化合物的药物组合物 | |
| CN110603041A (zh) | 用于治疗流感病毒感染的组合治疗 | |
| AU691490B2 (en) | Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans | |
| US20220409583A1 (en) | Treatment and Prevention of Dengue Disease | |
| JP2006515361A (ja) | ヘルペスウイルス感染の症候を治療又は予防する方法 | |
| US20130245108A1 (en) | Novel Antischistosomal Agent | |
| CA1147752A (en) | Isoprenylamines | |
| Fu et al. | Comparison of the different medications for COVID-19 in kidney transplant recipients | |
| US4303658A (en) | Antiviral pyrazolopyrazines | |
| CN107320471B (zh) | 一种治疗结核病的环丝氨酸药物组合物及其应用 | |
| CN113546067B (zh) | 具有抗病毒作用的蒽醌衍生物 | |
| CN118831089A (zh) | 土贝母皂苷甲在制备调节性t细胞分化抑制剂中的应用 | |
| US20210236496A1 (en) | Treatment of rsv with combination product | |
| NAIDU et al. | CHAPTER FOUR CHARACTERISTICS, PROPERTIES AND ANALYTICAL PROFILE OF ANTIRETROVIRAL DRUG MOLNUPIRAVIR (SARS-COV-2): A MINI REVIEW | |
| JPH03167125A (ja) | 抗水痘―帯状疱疹ウイルス剤 | |
| Jayanti et al. | Leucocytoclastic vasculitis in infant | |
| WO2023040990A1 (zh) | 治疗冠状病毒感染的新联用药物、药物组合物及其用途 | |
| Straube-West et al. | Enteroviruses | |
| CN113143920A (zh) | Ponesimod化合物在制备抗EV71病毒药物中的应用 |